SEC Filing Details
Document Details
Form
Filing Date
Aug 14, 2017
Document Date
Aug 8, 2017
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Aclaris Therapeutics, Inc.